Zefeng Shen

Zefeng Shen

Auto-generated profile, based on publicly available information

Zefeng Shen

The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
ZSZefeng Shen
Zefeng Shen
LGLihu Gu
Lihu Gu
DMDanyi Mao
Danyi Mao
MCManman Chen
Manman Chen
RJRongjia Jin
Rongjia Jin
To analyze the prognostic value of programmed death factor ligand 1 (PD-L1) in colorectal cancer. Electronic databases, such as PubMed, Web of Science, Embase, and Cochrane library, were searched to identify studies evaluating the PD-L1 expression and overall survival (OS) in these patients. Afterwards, the relevant data were extracted to perform the meta-analysis. A total of 3481 patients were included in 10 studies. The combined hazard ratio (HR) was 1.22 (95%CI = 1.01–1.48, P = 0.04), indicating that high expression of PD-L1 was significantly correlated with poor prognosis of colorectal cancer. Apropos of clinicopathological features, the merged odds ratio (OR) exhibited that highly expressed PD-L1 was firmly related to lymphatic invasion (OR = 3.49, 95%CI = 1.54–7.90, P = 0.003) and advanced stage (OR = 1.77, 95%CI = 1.41–2.23, P < 0.00001), but not correlative with patients’ gender, microsatellite instability, or tumor location. The expression of PD-L1 can be utilized as an independent factor in judging the prognosis of colorectal cancer, and patients with advanced cancer or lymphatic invasion are more likely to express PD-L1. This conclusion may lay a theoretical foundation for the application of PD-1/PD-L1 immunoassay point inhibitors but still needs verifying by sizeable well-designed cohort studies.